Showing results (411-420 of 471) with videos related to
Sort By:
Pageof 48
Medical Care|December 2, 2016
Measuring Harm in Health Care: Optimizing Adverse Event ReviewKathleen E Walsh, Polina Harik, Kathleen M Mazor, et al.The American Journal of Medicine|February 8, 2011
Randomized trial of a warfarin communication protocol for nursing homes: an SBAR-based approachTerry S Field, Jennifer Tjia, Kathleen M Mazor, et al.JAMA Internal Medicine|January 24, 2022
Association of Nursing Home Organizational Culture and Staff Perspectives With Variability in Advanced Dementia Care: The ADVANCE StudyRuth Palan Lopez, Meghan Hendricksen, Ellen P McCarthy, et al.Journal of the American Medical Directors Association|October 1, 2013
Knowledge of and perceived need for evidence-based education about antipsychotic medications among nursing home leadership and staffCeleste A Lemay, Kathleen M Mazor, Terry S Field, et al.Journal of General Internal Medicine|August 16, 2017
Primary Care Providers' Opening of Time-Sensitive Alerts Sent to Commercial Electronic Health Record InBasketsSarah L Cutrona, Hassan Fouayzi, Laura Burns, et al.Prostaglandins, Leukotrienes, and Essential Fatty Acids|March 1, 1996
Increase in prostaglandin bioavailability precedes the onset of human parturitionR Romero, H Munoz, R Gomez, et al.Journal of the American Geriatrics Society|March 1, 2023
Black and white proxy experiences and perceptions that influence advanced dementia care in nursing homes: The ADVANCE studyEllen P McCarthy, Ruth Palan Lopez, Meghan Hendricksen, et al.Vascular Medicine (London, England)|February 2, 2010
Attitudes and behavior of peripheral arterial disease patients toward influencing their physician's prescription of cholesterol-lowering medicationMary M McDermott, Kathleen M Mazor, George Reed, et al.Pediatrics|September 8, 2016
Patient Navigators and Parent Use of Quality Data: A Randomized TrialSarah L Goff, Kathleen M Mazor, Penelope S Pekow, et al.Journal of Perinatal Medicine|September 22, 2001
A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infectionE Maymon, R Romero, P Pacora, et al.Pageof 48